Aphios Corporation
PrivateLast Round
Grant
Dec 11, 2024
Est. Valuation
$70.09M
Total Funding Raised
$4.06M
Company Overview
Aphios Corporation is a biopharmaceutical company that develops enhanced therapeutics for health maintenance and the treatment of human diseases with a focus on infectious diseases, cancer, and central nervous system (CNS) disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Biotech Equipment
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aphios Corporation Comparables
Compare Aphios Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| StaniPharm | 77% | |
| Nanoform Finland Oyj | 74% | |
| Crystec Pharma | 72% |
Aphios Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 11, 2024 | ||||
| Grant | Sep 20, 2024 | ||||
| Grant | Sep 6, 2023 | ||||
| Grant | Mar 3, 2023 | ||||
| Crowdfunding | Jul 31, 2022 | ||||
Crowdfunding | Dec 31, 2019 |
Aphios Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| National Center for Complementary and Integrative Health | Grant |
| National Institute on Aging | Grant |
| Netcapital | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 11, 2024
$505K grant round led by National Institute on Aging.
- Sep 20, 2024
$416K grant from National Center for Complementary and Integrative Health.
Aphios Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aphios Corporation's valuation, stock price, and market status.
Is Aphios Corporation a public or private company?
Aphios Corporation is a private company.
What is the current stock price of Aphios Corporation?
Aphios Corporation is a private company with no public stock price. No recent secondary market data is available.
How much is Aphios Corporation worth (valuation)?
Aphios Corporation's valuation is estimated at $70.1M based on funding round data.
Can I buy Aphios Corporation stock?
Aphios Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aphios Corporation's last funding round?
Aphios Corporation's most recent funding round was Grant on July 31, 2022.
Who are the main investors in Aphios Corporation?
Key investors in Aphios Corporation include National Institute of Allergy and Infectious Diseases, NIH RADx, National Center for Complementary and Integrative Health, National Institute on Aging.
Will Aphios Corporation IPO soon?
No public IPO plans have been announced for Aphios Corporation.
How can I track Aphios Corporation secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aphios Corporation's secondary market activity and sign up for updates.